vancomycin has been researched along with mdl 62873 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biavasco, F; Lupidi, R; Varaldo, PE | 1 |
Bartoloni, A; Colao, MG; Dei, R; Giganti, E; Orsi, A; Parenti, F | 1 |
Biavasco, F; Manso, E; Varaldo, PE | 1 |
Goldstein, FW; Jones, RN; Zhou, XY | 1 |
Capodicasa, E; De Bellis, F; Del Favero, A; Marconi, P; Rosati, E; Sbaraglia, G; Scaringi, L | 1 |
Ena, J; Houston, A; Jones, RN; Wenzel, RP | 1 |
6 other study(ies) available for vancomycin and mdl 62873
Article | Year |
---|---|
In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
Topics: Actinomycetales; Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Listeria monocytogenes; Microbial Sensitivity Tests; Peptides, Cyclic; Ristocetin; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1992 |
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rifamycins; Ristocetin; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1990 |
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Depsipeptides; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Glycopeptides; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Ristocetin; Teicoplanin; Vancomycin | 1991 |
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; France; Glycopeptides; Microbial Sensitivity Tests; Ristocetin; Staphylococcus; Teicoplanin; United States; Vancomycin | 1991 |
In-vitro effects of teicoplanin, teicoplanin derivative MDL 62211 and vancomycin on human polymorphonuclear cell function.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Chemotaxis; Glycopeptides; Humans; Neutrophils; Phagocytosis; Ristocetin; Teicoplanin; Vancomycin | 1991 |
Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Hospitals, University; Humans; Lactams; Microbial Sensitivity Tests; Ristocetin; Staphylococcus; Time Factors; Vancomycin | 1993 |